BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38013377)

  • 21. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
    Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
    Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clear cell renal cell carcinoma: Machine learning-based computed tomography radiomics analysis for the prediction of WHO/ISUP grade.
    Shu J; Wen D; Xi Y; Xia Y; Cai Z; Xu W; Meng X; Liu B; Yin H
    Eur J Radiol; 2019 Dec; 121():108738. PubMed ID: 31756634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of radiomics machine-learning classifiers and feature selection for differentiation of sacral chordoma and sacral giant cell tumour based on 3D computed tomography features.
    Yin P; Mao N; Zhao C; Wu J; Sun C; Chen L; Hong N
    Eur Radiol; 2019 Apr; 29(4):1841-1847. PubMed ID: 30280245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.
    Nie P; Yang G; Wang Z; Yan L; Miao W; Hao D; Wu J; Zhao Y; Gong A; Cui J; Jia Y; Niu H
    Eur Radiol; 2020 Feb; 30(2):1274-1284. PubMed ID: 31506816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiomics Nomogram Based on Contrast-enhanced CT to Predict the Malignant Potential of Gastrointestinal Stromal Tumor: A Two-center Study.
    Song Y; Li J; Wang H; Liu B; Yuan C; Liu H; Zheng Z; Min F; Li Y
    Acad Radiol; 2022 Jun; 29(6):806-816. PubMed ID: 34238656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
    Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
    Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
    He H; Jin Z; Dai J; Wang H; Sun J; Xu D
    Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma.
    Chen M; Yin F; Yu Y; Zhang H; Wen G
    Cancer Imaging; 2021 Jun; 21(1):42. PubMed ID: 34162442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.
    Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
    BMC Med Imaging; 2020 Feb; 20(1):12. PubMed ID: 32024469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A CT-based radiomics model for predicting renal capsule invasion in renal cell carcinoma.
    Yang L; Gao L; Arefan D; Tan Y; Dan H; Zhang J
    BMC Med Imaging; 2022 Jan; 22(1):15. PubMed ID: 35094674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of predominant subtypes of lung adenocarcinoma using a quantitative radiomics approach on CT.
    Park S; Lee SM; Noh HN; Hwang HJ; Kim S; Do KH; Seo JB
    Eur Radiol; 2020 Sep; 30(9):4883-4892. PubMed ID: 32300970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT-based radiomics analysis of different machine learning models for differentiating benign and malignant parotid tumors.
    Zheng Y; Zhou D; Liu H; Wen M
    Eur Radiol; 2022 Oct; 32(10):6953-6964. PubMed ID: 35484339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
    Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
    Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of Lung Metastases Originated From Different Primary Tumors Using Radiomics Features Based on CT Imaging.
    Shang H; Li J; Jiao T; Fang C; Li K; Yin D; Zeng Q
    Acad Radiol; 2023 Jan; 30(1):40-46. PubMed ID: 35577699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Radiomics Models Based on Computed Tomography for Distinguishing Between Benign and Malignant Thyroid Nodules.
    Kong D; Zhang J; Shan W; Duan S; Guo L
    J Comput Assist Tomogr; 2022 Nov-Dec 01; 46(6):978-985. PubMed ID: 35759774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of osteoporosis using radiomics analysis derived from single source dual energy CT.
    Wang J; Zhou S; Chen S; He Y; Gao H; Yan L; Hu X; Li P; Shen H; Luo M; You T; Li J; Zhong Z; Zhang K
    BMC Musculoskelet Disord; 2023 Feb; 24(1):100. PubMed ID: 36750927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a machine learning-derived radiomics model for diagnosis of osteoporosis and osteopenia using quantitative computed tomography.
    Xie Q; Chen Y; Hu Y; Zeng F; Wang P; Xu L; Wu J; Li J; Zhu J; Xiang M; Zeng F
    BMC Med Imaging; 2022 Aug; 22(1):140. PubMed ID: 35941568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Value of CT-Based Radiomics in Distinguishing Renal Angiomyolipomas with Minimal Fat from Other Renal Tumors.
    Han Z; Zhu Y; Xu J; Wen D; Xia Y; Zheng M; Yan T; Wei M
    Dis Markers; 2022; 2022():9108129. PubMed ID: 35669501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.